Characterization and assessment of potential microRNAs involved in phosphate-induced aortic calcification
Loading...
Files
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley-Liss Inc.
Abstract
Medial artery calcification, a hallmark of type 2 diabetes mellitus and chronic kidney disease (CKD), is known as an independent risk factor for cardiovascular mortality and morbidity. Hyperphosphatemia associated with CKD is a strong stimulator of vascular calcification but the molecular mechanisms regulating this process remain not fully understood. We showed that calcification was induced after exposing Sprague-Dawley rat aortic explants to high inorganic phosphate level (P i , 6 mM) as examined by Alizarin red and Von Kossa staining. This calcification was associated with high Tissue-Nonspecific Alkaline Phosphatase (TNAP) activity, vascular smooth muscle cells de-differentiation, manifested by downregulation of smooth muscle 22 alpha (SM22α) protein expression which was assessed by immunoblot analysis, immunofluorescence, and trans-differentiation into osteo-chondrocyte-like cells revealed by upregulation of Runt related transcription factor 2 (Runx2), TNAP, osteocalcin, and osteopontin mRNA levels which were determined by quantitative real-time PCR. To unravel the possible mechanism(s) involved in this process, microRNA (miR) expression profile, which was assessed using TLDA technique and thereafter confirmed by individual qRT-PCR, revealed differential expression 10 miRs, five at day 3 and 5 at day 6 post P i treatment versus control untreated aortas. At day 3, miR-200c, -155, 322 were upregulated and miR-708 and 331 were downregulated. After 6 days of treatment, miR-328, -546, -301a were upregulated while miR-409 and miR-542 were downregulated. Our results indicate that high P i levels trigger aortic calcification and modulation of certain miRs. These observations suggest that mechanisms regulating aortic calcification might involve miRs, which warrant further investigations in future studies. © 2017 Wiley Periodicals, Inc.
Description
Keywords
Aorta, Calcification, Inorganic phosphate, Micrornas, Trans-differentiation, Alkaline phosphatase, Animals, Calcification, physiologic, Cell dedifferentiation, Core binding factor alpha 1 subunit, Diabetes mellitus, type 2, Gene expression regulation, Humans, Hyperphosphatemia, Microfilament proteins, Muscle proteins, Muscle, smooth, vascular, Osteocalcin, Phosphates, Rats, Renal insufficiency, chronic, Alpha smooth muscle actin, Messenger rna, Microrna, Microrna 107, Microrna 133b, Microrna 135a, Microrna 155, Microrna 186, Microrna 200c, Microrna 223, Microrna 296, Microrna 301a, Microrna 322, Microrna 323, Microrna 328, Microrna 331, Microrna 345, Microrna 375, Microrna 409, Microrna 491, Microrna 542, Microrna 546, Microrna 598, Microrna 708, Osteopontin, Phosphate, Tissue nonspecific alkaline phosphatase, Transcription factor runx2, Unclassified drug, Actin binding protein, Alpl protein, human, Mirn328 microrna, rat, Muscle protein, Runx2 protein, rat, Transgelin, Alizarin red staining, Animal experiment, Animal tissue, Artery calcification, Article, Cell transdifferentiation, Chondrocyte, Controlled study, Enzyme activity, Explant, Gene expression profiling, Immunoblotting, Male, Nonhuman, Priority journal, Protein expression, Rat, Real time polymerase chain reaction, Sprague dawley rat, Staining, Upregulation, Vascular smooth muscle cell, Von kossa staining, Animal, Bone mineralization, Chronic kidney failure, Drug effect, Genetics, Human, Metabolism, Non insulin dependent diabetes mellitus, Pathology, Pathophysiology, Vascular smooth muscle